Overview

To Evaluate 24-hr Glucose After OD vs BD AZD1656

Status:
Completed

Trial end date:
2009-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the 24-hour glucose profiles in diabetic patients treated with metformin following once daily and twice daily oral dosing

Phase:

Phase 1

Details

Lead Sponsor:

AstraZeneca